Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Immune thrombocytopenia (ITP), previously called immune thrombocytopenic purpura or idiopathic thrombocytopenic purpura, is an autoimmune disorder that occurs when the body attacks its own platelets and destroys them too quickly. Platelets are a part of blood that helps control bleeding.
While ITP often arises after a viral infection, for the majority of cases the cause is unknown. Luckily, acute ITP, the most common form, usually goes away on its own over the course of weeks or months, sometimes without treatment. Chronic ITP appears most frequently in adults, but occasionally is seen in children. This form of ITP is more serious, lasting for years and typically requiring specialized follow-up care.
Children and young adults with immune thrombocytopenia are treated through the Blood Disorders Center at Dana-Farber/Boston Children's, where children and teens receive care from some of the world's most experienced hematologists with deep experience in the conditions they treat.
Find in-depth information on ITP on the Dana-Farber/Boston Children's website, including answers to:
Appointments and Second Opinions